Stock 688578 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shanghai Allist Pharmaceuticals Co., Ltd.

Equities

688578

CNE100005XJ7

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
61.9 CNY -2.60% Intraday chart for Shanghai Allist Pharmaceuticals Co., Ltd. +6.50% +48.58%
05-09 Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib MT
04-25 Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib
MT
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
AQ
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Allist Pharmaceuticals Co., Ltd.(XSSC:688578) added to S&P Global BMI Index
CI
InnoCare Announces Approval of Clinical Trial of SHP2 Inhibitor ICP-189 in Combination with EGFR Inhibitor Furmonertinib
AQ
Allist Pharmaceuticals Co., Ltd. and ArriVent Biopharma, Inc. Announce Interim Results from Ongoing Phase 1B Trial with Furmonertinib At the 2023 World Conference on Lung Cancer
CI
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Allist Pharmaceuticals Gets Nod to Advance Trial of Lung Cancer Treatment
MT
Chinese healthcare stocks hit by stepped up anti-graft crackdown
RE
Shanghai Allist Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688578 Stock
  4. News Shanghai Allist Pharmaceuticals Co., Ltd.